Prostaglandin E1 in treatment of patients with early diabetic nephropathy

朱炜丹,陈丽华,陈江华
2014-01-01
Abstract:Objective To evaluate the efficacy of prostaglandin E1 in treatment of patients with early diabetic nephropa-thy (DN). Methods Sixty patients with early DN were divided into observation group and control group. On the bases of routine therapy, patients in observation group (n=30) received prostaglandin E1(10μg in 0.9%normal saline, intravenous drip), patients in control group (n=30) received same volume of normal saline for 2 weeks. 24h urinary albumin excretion rate and endothelial function von Wil ebrand factor (vWF) levels were measured before and after treatment. Results There were no significant differ-ences in UAER and vWF levels between two groups before treatment. UAER and vWF levels in both group were improved sig-nificantly after treatment (al P<0.01), however, compared to control group these indexes were improved more markedly in ob-servation group (P<0.01). Conclusion Prostaglandin El can improve vascular endothelial function in patients with early DN with the reduction of UAER and vWF levels.
What problem does this paper attempt to address?